| Literature DB >> 23617307 |
Dawn Me Bowdish1, Kaori Sakamoto, Nathan A Lack, Philip C Hill, Giorgio Sirugo, Melanie J Newport, Siamon Gordon, Adrian Vs Hill, Fredrick O Vannberg.
Abstract
BACKGROUND: The two major class A scavenger receptors are scavenger receptor A (SRA), which is constitutively expressed on most macrophage populations, and macrophage receptor with collagenous structure (MARCO), which is constitutively expressed on a more restricted subset of macrophages, (e.g. alveolar macrophages) but whose expression increases on most macrophages during the course of infection. Although the primary role of SRA appears to be clearance of modified host proteins and lipids, mice defective in expression of either MARCO or SRA are immunocompromised in multiple models of infection and in vitro assays, the scavenger receptors have been demonstrated to bind bacteria and to enhance pro-inflammatory signalling to many bacterial lung pathogens; however their importance in Mycobacterium tuberculosis infection, is less clear.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23617307 PMCID: PMC3652798 DOI: 10.1186/1471-2350-14-47
Source DB: PubMed Journal: BMC Med Genet ISSN: 1471-2350 Impact factor: 2.103
Characteristics of study population
| 712 | 40.6% | 1043 | 59.4% | 1755 | <0.001 | ||
| | 784 | 63.3% | 455 | 36.7% | 1239 | | |
| 454 | 47.8% | 495 | 52.2% | 949 | 0.250 | ||
| | 287 | 56.9% | 217 | 43.1% | 504 | 0.004 | |
| | 296 | 58.7% | 208 | 41.3% | 504 | <0.001 | |
| | 263 | 71.3% | 106 | 28.7% | 369 | <0.001 | |
| | 190 | 28.8% | 470 | 71.2% | 660 | <0.001 | |
| | 6 | 75.0% | 2 | 25.0% | 8 | | |
| 1496 | 1498 | 2994 |
*Standard Chi-Square tests with 1 degree of freedom were performed for comparing groups.
Figure 1Haploview analysis of SNPs in [GeneID: 8685], located on chromosome 2q12. Linkage Disequilibrium (LD) in the African population is visualized across the MARCO locus, including upstream and downstream regions (chr2: 119414167–119468337). Polymorphisms are identified by their dbSNP rs numbers, and their position relative to the gene structure is marked. SNPs marked in bold were typed in this study. SNPs marked in green were included in the Wellcome Trust Case Control consortium [32] analysis and were used in validation studies. Empty squares indicate a high degree of LD (LD coefficient D' = 1) between pairs of markers. Numbers indicate the D' value expressed as a percentile. Black squares indicate pairs in strong LD with logarithm of odds (LOD) scores for LD ≥2; grey squares, D' < 1 with LOD ≥2; white squares, D' < 1.0 and LOD < 2.
Association analysis of SNPs in a Gambian tuberculosis case control study
| 2 | | rs17180481 | 119414167 | 5.2 | 7.60E-02 | 4.2 | 4.10E-02 |
| 2 | | rs6748401 | 119414287 | 3.9 | 1.40E-01 | 0 | 8.30E-01 |
| 2 | | rs6748401 | 119414527 | 2.6 | 2.80E-01 | 0.5 | 4.90E-01 |
| 2 | | rs17009242 | 119415253 | 1.6 | 4.50E-01 | 1.6 | 2.10E-01 |
| 2 | | rs17009268 | 119415479 | NA | NA | NA | NA |
| 2 | | rs1073529 | 119421449 | 1.8 | 4.20E-01 | 1.7 | 1.90E-01 |
| 2 | | rs1985119 | 119426870 | 1.3 | 5.20E-01 | 1.2 | 2.70E-01 |
| 2 | | rs4491733 | 119434498 | 12.3 | 2.10E-03 | 6.5 | 1.10E-02 |
| 2 | | rs7559955 | 119441199 | ||||
| 2 | | rs12998782 | 119441610 | 7.3 | 2.60E-02 | 6.5 | 1.10E-02 |
| 2 | | rs2119112 | 119442389 | 1 | 6.10E-01 | 0.4 | 5.10E-01 |
| 2 | | rs2278589 | 119445346 | 0 | 9.90E-01 | 0 | 9.60E-01 |
| 2 | | rs11693199 | 119448272 | 5.9 | 5.10E-02 | 3.1 | 7.90E-02 |
| 2 | | rs1371562 | 119449418 | 0.1 | 9.30E-01 | 0.1 | 7.10E-01 |
| 2 | | rs10204875 | 119453881 | 2.9 | 2.40E-01 | 1.4 | 2.30E-01 |
| 2 | | rs12997087 | 119454047 | 0.6 | 7.60E-01 | 0.4 | 5.20E-01 |
| 2 | | rs1371565 | 119454355 | 0.5 | 7.80E-01 | 0.5 | 4.90E-01 |
| 2 | | rs1371566 | 119454417 | 0.5 | 7.60E-01 | 0.4 | 5.50E-01 |
| 2 | | rs6761637 | 119455533 | 1.1 | 5.80E-01 | 1 | 3.20E-01 |
| 2 | | rs7599352 | 119456760 | 1.5 | 4.70E-01 | 1.1 | 2.90E-01 |
| 2 | | rs13389814 | 119458420 | ||||
| 2 | | rs3731611 | 119459081 | 1.7 | 4.30E-01 | 1.6 | 2.10E-01 |
| 2 | | rs3731612 | 119459335 | 1.7 | 4.30E-01 | 1.6 | 2.10E-01 |
| 2 | | rs12987402 | 119465026 | 1.6 | 4.40E-01 | 1.3 | 2.50E-01 |
| 2 | rs11678719 | 119468337 | 5.1 | 7.70E-02 | 0.7 | 4.00E-01 | |
The T allele of rs7559955 shows heterozygote protection
| 1123 | |||
| 1204 | |||
| 306 | |||
| 1349 | 1284 | 2633 | |
| | 40.2% | 45.2% | |
| | 48.3% | 43.1% | |
| | 11.6% | 11.7% | |
| HW P | 0.060 | 0.295 |
Figure 2TESS Analysis of potential transcription factor binding. The T variant allele creates potential for EFII and C/EBPalpha binding. A) The rs7559955 allele in intron 1 is found in a region of high conservation. Alignments of the homologous region from human, chimpanzee, macaque, mouse, rat, dog, and cow were performed, and the region of high conservation, and thus high regulatory potential as determined by ESPERR, is marked in blue. B) Transcription factor binding site analysis using TESS indicates that the presence of the T allele may confer the addition of EFII or C/EBPalpha transcription factor binding sites.